Soleno Therapeutics Inc.

AI Score

XX

Unlock

73.78
-0.45 (-0.61%)
At close: Apr 25, 2025, 11:00 AM

Soleno Therapeutics Statistics

Share Statistics

Soleno Therapeutics has 49.96M shares outstanding. The number of shares has increased by 25.94% in one year.

Shares Outstanding 49.96M
Shares Change (YoY) 25.94%
Shares Change (QoQ) 6.35%
Owned by Institutions (%) 99.99%
Shares Floating 39.65M
Failed to Deliver (FTD) Shares 323.58K
FTD / Avg. Volume 27.36%

Short Selling Information

The latest short interest is 4.66M, so 10.81% of the outstanding shares have been sold short.

Short Interest 4.66M
Short % of Shares Out 10.81%
Short % of Float 16.51%
Short Ratio (days to cover) 1.59

Valuation Ratios

The PE ratio is -10.27 and the forward PE ratio is 7223. Soleno Therapeutics's PEG ratio is -0.12.

PE Ratio -10.27
Forward PE 7223
PS Ratio 0
Forward PS 3.2
PB Ratio 7.37
P/FCF Ratio -26.05
PEG Ratio -0.12
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Soleno Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 15.68, with a Debt / Equity ratio of 0.01.

Current Ratio 15.68
Quick Ratio 15.68
Debt / Equity 0.01
Debt / EBITDA -
Debt / FCF -0.04
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.91M
Employee Count 92
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 98.45% in the last 52 weeks. The beta is -2.29, so Soleno Therapeutics's price volatility has been lower than the market average.

Beta -2.29
52-Week Price Change 98.45%
50-Day Moving Average 56.07
200-Day Moving Average 51.32
Relative Strength Index (RSI) 66.28
Average Volume (20 Days) 1.18M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income -175.85M
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -4.38
Full Income Statement

Balance Sheet

The company has 87.93M in cash and 3M in debt, giving a net cash position of 84.93M.

Cash & Cash Equivalents 87.93M
Total Debt 3M
Net Cash 84.93M
Retained Earnings -452.26M
Total Assets 330.97M
Working Capital 275.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -69.1M and capital expenditures -218K, giving a free cash flow of -69.31M.

Operating Cash Flow -69.1M
Capital Expenditures -218K
Free Cash Flow -69.31M
FCF Per Share -1.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SLNO is $102, which is 37.7% higher than the current price. The consensus rating is "Buy".

Price Target $102
Price Target Difference 37.7%
Analyst Consensus Buy
Analyst Count 8
Stock Forecasts

Stock Splits

The last stock split was on Aug 26, 2022. It was a backward split with a ratio of 1:15.

Last Split Date Aug 26, 2022
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score 20.08
Piotroski F-Score 2